EN DE
STOCK COMPARISON

Balsm Alofoq Medical vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Balsm Alofoq Medical (9620) and Abbott Laboratories (ABT) compare, as of Sep 15, 2026.

As of Sep 15, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Balsm Alofoq Medical trades at SAR 22.86 versus a fair value of SAR 10.54 (-54%), while Abbott Laboratories trades at $103 versus $74.79 (-27%).
Balsm Alofoq Medical
9620.SR · SAR · Health Care
-54%
upside to fair value
overvalued
PriceSAR 22.86
Fair ValueSAR 10.54
Quality32/100
Abbott Laboratories
ABT · USD · Health Care
-27%
upside to fair value
overvalued
Price$103
Fair Value$74.79
Quality66/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Balsm Alofoq MedicalAbbott Laboratories
Valuation
29.7×P/E (TTM)27.7×
0.82×P/S (TTM)3.89×
0.54×P/B3.36×
1.7×EV/EBITDA15.1×
—PEG1.47×
−53.9%Fair value upside−27.5%
4.9%Dividend yield2.3%
—Dividend per share$2.44
Profitability
10%Operating margin13%
0.58×EBIT margin trend (5Y)1.19×
7%Return on equity12%
5%Return on assets6%
Growth
3%Revenue growth (YoY)8%
6.2%Avg. growth/yr (3Y)0.5%
—Avg. growth/yr (5Y)5.1%
−15.0%Value creation/yr+10.5%
Balance & size
19.7×Interest coverage (EBIT/interest)23.6×
—Debt / equity0.19×
$17MMarket cap$175B
expensiveGrowth qualityhealthy

Abbott Laboratories leads: 5 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Balsm Alofoq Medicalof which business quality 36 · market factors 26 Abbott Laboratoriesof which business quality 66 · market factors 50
ProfitabilityMargins and returns on capital today
40
50
Quality GrowthAre margins and returns improving?
13
47
CashflowEarnings quality: real cash, not paper profit
0
71
Fin. StrengthBalance sheet, leverage, solvency risk
100
80
InvestmentDisciplined investing over empire-building
0
65
Low VolatilityCalm price path (market factor)
34
83
MomentumPrice trend over the last 3–12 months (market factor)
29
41
52W MomentumDistance to the 52-week high (market factor)
10
26
Net IssuanceShare count: buybacks or dilution?
42
84

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyBalsm Alofoq MedicalPrice SAR 22.86Abbott LaboratoriesPrice $103
DCF Modelsn/a-29%below the price$73.01
Earnings-Based-49%below the priceSAR 11.71-71%below the price$29.42
Dividend Discount-45%below the priceSAR 12.54-61%below the price$39.73
Multiples-23%below the priceSAR 17.50-31%below the price$70.72
Asset-Based-64%below the priceSAR 8.28-81%below the price$20.05
Growth DCFn/a-35%below the price$67.02
Economic Profit-54%below the priceSAR 10.44-64%below the price$37.49
Growth Earnings-37%below the priceSAR 14.34-32%below the price$70.25
Minimum-64%below the priceSAR 8.28-81%below the price$20.05
Maximum-23%below the priceSAR 17.50-29%below the price$73.01
Median-47%below the priceSAR 12.13-48%below the price$53.37
Geometric mean-47%below the priceSAR 12.13-55%below the price$46.36

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Balsm Alofoq Medical: 14 of 15 models see the stock below the current price.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Balsm Alofoq Medical
Price SAR 22.86
Fair Value SAR 10.54
Bear SAR 7.48Bull SAR 13.90
Abbott Laboratories
Price $103
Fair Value $74.79
Bear $51.13Bull $94.43

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Balsm Alofoq Medical · Health Care

Quality score32 · bottom 25%
Fair value upside-54% · below median

Abbott Laboratories · Health Care

Quality score66 · Top 25%
Fair value upside-27% · below median

Bottom line

As of Sep 15, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Balsm Alofoq Medical trades at SAR 22.86 versus a fair value of SAR 10.54 (-54%), while Abbott Laboratories trades at $103 versus $74.79 (-27%).

Abbott Laboratories has the higher quality score (66/100).

See the full analysis →
Balsm Alofoq Medical · Abbott Laboratories

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Balsm Alofoq Medical

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Abbott Laboratories

Microsoft vs Taiwan Semiconductor ManufacturingAlphabet Inc Class C vs Meta PlatformsBroadcom vs MicrosoftMicrosoft vs Micron Technology
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.